Yulia Hirschberg
Novartis (United States)(US)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Fatty Acid Research and Health, Clinical Nutrition and Gastroenterology, Renal and related cancers
Most-Cited Works
- → Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.(2000)71 cited
- → Decreased loss of liver adenosine triphosphate during hypothermic preservation in rats pretreated with glucose: Implications for organ donor management(1988)50 cited
- → Single‐Dose Pharmacokinetics of Nateglinide in Subjects with Hepatic Cirrhosis(2000)44 cited
- → Serum fatty acid profiles after intravenous medium chain triglyceride administration(1989)38 cited
- → Molecular basis of cardiac troponin T isoform heterogeneity in rabbit heart.(1994)37 cited
- → GLYCOLYTIC SUPPORT OF ADENINE NUCLEOTIDES IN RAT LIVER FLUSH-PRESERVED WITH UW OR COLLINSʼ II(1989)35 cited
- → Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)(2019)28 cited
- → Short-term TPN containing n-3 fatty acids ameliorate lactic acidosis induced by endotoxin in guinea pigs(1990)26 cited
- → The effects of chronic fish oil feeding in rats on protein catabolism induced by recombinant mediators(1990)22 cited
- → Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919)(2001)20 cited